Company news
Scancell Holdings PLC news in 2024
Scancell Holdings PLC's news releases, calls and decks from 2024, newest first.
Result of Retail Offer and Total Voting Rights
December 9, 2024
Result of Placing and Subscription
December 5, 2024
Retail Offer for up to £1 million
December 4, 2024
Proposed fundraise in excess of £8.5 million
December 4, 2024
Second Commercial License Agreement with Genmab
December 4, 2024
Positive data from Phase 2 SCOPE trial with SCIB1
November 18, 2024
Result of Annual General Meeting
October 25, 2024
Holding(s) in Company
October 24, 2024
Scancell Appoints Dr Phil L’Huillier as CEO
October 22, 2024
Results Year Ended 30 April 2024
September 24, 2024
Notice of Final Results
September 18, 2024
Strategic Partnership with PharmaJet
September 17, 2024
Scancell to attend upcoming conferences
September 2, 2024
Scancell Appoints Dr Nermeen Varawalla as CMO
July 30, 2024
Update from iSCIB1+ Clinical Advisory Meeting
July 24, 2024
Appointment of Dr Florian Reinaud to the Board
July 10, 2024
Extension of Convertible Loan Notes
July 2, 2024
Block Listing Return and Total Voting Rights
July 1, 2024
Change of Nominated Advisor
June 21, 2024
Agreement with major biotech
June 12, 2024
Update on ModiFY trial
May 30, 2024
Scancell to present at ASCO Annual Meeting
May 24, 2024
Presenting at the Sachs 10th Annual Oncology Forum
May 16, 2024
Scancell presenting at 21st CIMT Annual Meeting
May 9, 2024
Presenting at the Annual Immuno-Oncology Summit
April 17, 2024
Block Listing Six Monthly Return
April 16, 2024
Employee exercise of share options
April 3, 2024
Scancell to Present at 2024 AACR Annual Meeting
April 2, 2024
Scancell Appoints WG as Joint Broker
March 28, 2024
First iSCIB1+ patient dosed
March 26, 2024
Appointment of Sath Nirmalananthan to the Board
March 14, 2024
Scancell Attendance at Upcoming Conferences
March 12, 2024
Presenting at Next-Gen Immuno-Oncology Conference
March 4, 2024
Change of Auditor
February 20, 2024
Directorate Change
February 5, 2024
Notice of Interim Results and Presentation
January 26, 2024
Update on SCOPE trial
January 17, 2024
Decks in 2024
- FY2024 Earnings Presentation
Earnings · 20 slides · Sep 24, 2024